Trade 3SBio Inc. - 1530 CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.15 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.020513% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.001405% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 10 | ||||||||
| Currency | HKD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Hong Kong | ||||||||
| Commission on trade | 0% |
| Prev. Close | 12.9 |
| Open | 12.6 |
| 1-Year Change | 111.76% |
| Day's Range | 12.5 - 13.6 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 3, 2025 | 12.50 | -0.20 | -1.57% | 12.70 | 13.65 | 12.50 |
| Apr 2, 2025 | 12.90 | -0.05 | -0.39% | 12.95 | 13.35 | 12.60 |
| Apr 1, 2025 | 13.00 | 1.10 | 9.24% | 11.90 | 13.40 | 11.90 |
| Mar 31, 2025 | 11.90 | 0.00 | 0.00% | 11.90 | 12.50 | 11.65 |
| Mar 28, 2025 | 12.20 | -0.10 | -0.81% | 12.30 | 13.00 | 11.90 |
| Mar 27, 2025 | 11.95 | 1.20 | 11.16% | 10.75 | 12.35 | 10.50 |
| Mar 26, 2025 | 10.85 | 1.20 | 12.44% | 9.65 | 10.95 | 9.65 |
| Mar 25, 2025 | 9.70 | -0.75 | -7.18% | 10.45 | 10.65 | 9.55 |
| Mar 24, 2025 | 10.60 | 0.30 | 2.91% | 10.30 | 10.95 | 10.25 |
| Mar 21, 2025 | 10.30 | -0.15 | -1.44% | 10.45 | 10.95 | 9.95 |
| Mar 20, 2025 | 10.55 | 0.80 | 8.21% | 9.75 | 10.70 | 9.65 |
| Mar 19, 2025 | 9.80 | 0.30 | 3.16% | 9.50 | 9.90 | 9.50 |
| Mar 18, 2025 | 9.50 | 0.10 | 1.06% | 9.40 | 9.85 | 9.35 |
| Mar 17, 2025 | 9.40 | -0.45 | -4.57% | 9.85 | 9.95 | 9.25 |
| Mar 14, 2025 | 9.65 | 0.70 | 7.82% | 8.95 | 9.80 | 8.90 |
| Mar 13, 2025 | 8.90 | -0.25 | -2.73% | 9.15 | 9.45 | 8.90 |
| Mar 12, 2025 | 8.90 | 0.30 | 3.49% | 8.60 | 9.35 | 8.50 |
| Mar 11, 2025 | 8.45 | 0.45 | 5.62% | 8.00 | 8.70 | 8.00 |
| Mar 10, 2025 | 8.10 | 0.40 | 5.19% | 7.70 | 8.20 | 7.70 |
| Mar 7, 2025 | 7.45 | 0.05 | 0.68% | 7.40 | 7.80 | 7.40 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
3SBio Company profile
3SBio Inc. develops, manufactures, markets, and sells biopharmaceuticals. The company's primary products include TPIAO, a recombinant human thrombopoietin for thrombocytopenia; Yisaipu, a tumour necrosis factor for treating rheumatoid arthritis, ankylosing spondylitis, and psoriasis; and EPIAO, a recombinant human erythropoietin for the treatment of anemia associated with chronic kidney disease (CKD), chemotherapy-induced anemia, and reduction of allogeneic blood transfusion in surgery patients. Its primary products also comprise SEPO, a recombinant human erythropoietin for anemia associated with CKD and chemotherapy; Byetta/Bydureon, an exenatide injection to improve glycemic control in adults with type-2 diabetes mellitus; and Qiming Keli for retinopathy caused by type-2 diabetes. In addition, the company offers Ruisiyi to treat advanced breast cancer; Wanwei for treating vomiting caused by cytotoxic chemotherapy; and Intefen to treat lymphatic or hematopoietic malignancies and viral infections. Further, it provides Inleusin for renal cell carcinoma, melanoma, thoracic fluid build-up caused by cancer, and tuberculosis; Etanercept for moderate to severe rheumatoid arthritis and plaque psoriasis, and active ankylosing spondylitis; and Sparin for prophylaxis and vein thrombosis, and to prevent clotting during hemodialysis. Additionally, the company offers Mandi for male-pattern alopecia and alopecia areata; Aiyishu for iron-deficiency anemia; Disu to prevent and treat chronic bronchitis, colds, and asthma; Jiannipai to prevent acute rejection after renal transplantation; and Humulin for diabetes, as well as contract development and manufacturing, trading, project management and consultation, and technology services. The company markets its products through in-house sales and marketing team, as well as distributors and third-party promoters. 3SBio Inc. was incorporated in 2006 and is headquartered in Shenyang, the People's Republic of China.| Industry: | Biopharmaceuticals |
瀋陽經濟技術開發區十號路1甲3號
SHENYANG
LIAONING
CN
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com